The use of combination vaccines has improved timeliness of vaccination in children

Helen Kalies1, Veit Grote, Thomas Verstraeten

  • 1Department of Pediatric Epidemiology, Institute for Social Pediatrics and Adolescent Medicine of Ludwig-Maximilians-University, Munich, Germany. kalies@uni-muenchen.de

Insights

Combination vaccines significantly improved timely infant immunizations in Germany. The use of higher-valent vaccines, like the hexavalent vaccine, led to earlier and more complete vaccinations for Haemophilus influenzae type b, polio, and hepatitis B.

Area of Science:

  • Pediatric Vaccinology
  • Public Health Policy
  • Immunization Programs

Background:

  • Germany utilizes combination vaccines for diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b (Hib), polio, and hepatitis B (HBV).
  • The study investigates the impact of these combination vaccines on vaccination timeliness.

Purpose of the Study:

  • To determine if the introduction of combination vaccines in Germany has improved the timeliness of infant immunizations.
  • To compare vaccination schedules and completion rates associated with different valencies of combination vaccines.

Main Methods:

  • Analysis of vaccination data from 2701 children born between 1996-2003 in Germany via nationwide telephone interviews.
  • Assessment of up-to-date vaccination status at 3, 5, and 15 months for different vaccine types.
  • Comparison of median ages for vaccination initiation and completion across monovalent and various multivalent combination vaccines.

Main Results:

  • Transition from monovalent to higher-valent combination vaccines (4-, 5-, and 6-valent) correlated with increased up-to-date vaccination rates for Hib, polio, and HBV.
  • Significant improvements in median age for first dose and full immunization were observed with hexavalent vaccines compared to monovalent vaccines.
  • Intermediate improvements were noted with 4- and 5-valent vaccines, with differences remaining significant across birth cohorts.

Conclusions:

  • Combination vaccines, beyond reducing injection numbers, have demonstrably enhanced the timeliness of infant immunizations in Germany.
  • The findings support the adoption of higher-valent combination vaccines for improved public health outcomes in pediatric vaccination schedules.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...